Sustainability to drive Pregis product development in Europe

Published: 10-Dec-2010
Packaging Finance

To focus on environmentally friendly products in 2011

The new president of Pregis’ European protective packaging business says the firm will focus on sustainable products in new product developments for 2011.

Kevin Baudhuin has been president of Pregis’ North American protective packaging business since 2007.

He has now been promoted to president of global protective packaging where he will lead Pregis Protective Packaging Europe.

Baudhuin said the firm aimed to create a broad environmentally friendly product portfolio suitable for a number of markets, including medical and pharmaceutical products.

The company already offers its Superlite poly Mailer and EP-Flex Renew biodegradable film products.

‘We recognise that any sustainable solution must still meet other key requirements such as high performance and cost-effectiveness and we will therefore ensure that our products continue to satisfy all these criteria,’ said Baudhuin.

He added that the firm’s growth strategy would focus on three main areas of sustainability, innovation and customer partnerships.

See more

You may also like

Manufacturing

Pregis announces film converting, equipment assembly facilities

Read more
The company’s converting equipment has been self-manufactured and was designed to ensure it’s capable of meeting performance goals including output, sealing and puncture resistance

Trending Articles

  1. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
  2. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
  3. SGD Pharma partners with Prince Sterilisation Services for pharmaceutical glass packaging The pair have already launched the My Sterinity Nasal platform, a new, versatile sterile vial range within SGD Pharma's My Sterinity RTU platform, using the company's U-Save Type I vials, which are designed to support the growing segment of high-value nasal drug delivery
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
  5. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals

Upcoming event

Cleanroom Technology Awards 2026

13 April | Virtual See all

You may also like

Manufacturing

Pregis announces film converting, equipment assembly facilities

The company’s converting equipment has been self-manufactured and was designed to ensure it’s capable of meeting performance goals including output, sealing and puncture resistance
Packaging

Pregis launches high speed bagger with predictive maintenance

The unit features an intuitive user interface and thermal printing technology, which prints bar codes, graphics and alphanumeric fonts directly onto the package
Packaging

Pregis adds bagging systems to protective packaging portfolio

The protective packaging company has acquired Sharp Packaging Systems and its flexible bagging systems capability
Packaging

Pregis acquires UK-based protective packaging company Easypack

Will expand its North American portfolio to include paper void fill, cushioning and block/brace solutions
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Investing in the future of healthcare: from diagnostics innovation to scientific talent pipelines

Strategic UK investment in next-generation cancer diagnostics and cardiovascular research training is accelerating innovation, reducing barriers to adoption and building the multidisciplinary talent needed to deliver long-term improvements in patient outcomes and life sciences growth
Research & Development

Just – Evotec Biologics wins BARDA contract to optimise antibody biomanufacturing against Ebola and Sudan virus

Just – Evotec Biologics has been selected by BARDA to develop scalable, high-yield manufacturing processes for a monoclonal antibody cocktail targeting filovirus diseases under a multi-year programme valued at up to $10m
Finance

Apollo takes 37% stake in Syntegon as CVC eyes next phase of pharmaceutical packaging growth

CVC will retain majority control of the Stuttgart-based equipment specialist as the partnership targets North American expansion and a 72,000-strong installed base service opportunity
Subscribe now